104 related articles for article (PubMed ID: 6121897)
1. Effects of subacute oral administration of captopril (SQ 14,255) on the renin-angiotensin system in spontaneously hypertensive rats.
Pong SF; Moore AF; Huang CT; Ellis KO
J Pharm Pharmacol; 1982 Mar; 34(3):186-7. PubMed ID: 6121897
[No Abstract] [Full Text] [Related]
2. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
Hashimoto H; Hiwada K; Kokubu T
Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of the effect of captopril on blood pressure and angiotensin converting enzyme in serum and lungs of spontaneously hypertensive rats.
Forslund T; Tikkanen I; Grönhagen-Riska C; Fyhrquist F
Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):416-21. PubMed ID: 6285670
[TBL] [Abstract][Full Text] [Related]
4. Effect of captopril on brain converting enzyme in the spontaneously hypertensive rat.
Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
Clin Exp Pharmacol Physiol; 1984; 11(3):237-44. PubMed ID: 6086193
[TBL] [Abstract][Full Text] [Related]
5. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
[TBL] [Abstract][Full Text] [Related]
6. Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats.
Levens NR; Peach MJ; Vaughan ED; Weed WC; Carey RM
Endocrinology; 1981 Feb; 108(2):536-44. PubMed ID: 6256155
[TBL] [Abstract][Full Text] [Related]
7. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
Komori T; Takada T; Funae Y; Yamamoto K
Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
[No Abstract] [Full Text] [Related]
8. The central and peripheral effects of Captopril (SQ 14225) on the arterial pressure of the spontaneously hypertensive rat.
Stamler JF; Brody MJ; Phillips MI
Brain Res; 1980 Mar; 186(2):499-503. PubMed ID: 6986956
[No Abstract] [Full Text] [Related]
9. Endocrine mechanisms in the pathogenesis of essential hypertension. VI. Blockade of the renin-angiotensin system as a therapeutical basis.
Păuşescu E
Physiologie; 1982; 19(4):245-64. PubMed ID: 6185963
[No Abstract] [Full Text] [Related]
10. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
Baum T; Becker FT; Sybertz EJ
Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure regulation by angiotensin in the spontaneously hypertensive rats.
Sokabe H; Kawashima K; Watanabe TX
Adv Exp Med Biol; 1979; 120B():429-35. PubMed ID: 390989
[TBL] [Abstract][Full Text] [Related]
13. Plasma-converting enzyme activity does not reflect effectiveness of oral treatment with captopril.
Unger T; Schüll B; Hübner D; Yukimura T; Lang RE; Rascher W; Ganten D
Eur J Pharmacol; 1981 Jun; 72(2-3):255-9. PubMed ID: 6265248
[TBL] [Abstract][Full Text] [Related]
14. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C
Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343
[TBL] [Abstract][Full Text] [Related]
15. [Effects of angiotensin converting enzyme inhibitor captopril on blood pressure in "juvenile" essential hypertension].
Ando K; Fujita T; Sato Y; Yanashita K; Noda H
Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):399-404. PubMed ID: 6750184
[No Abstract] [Full Text] [Related]
16. Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension.
Morganti A; Sala C; Turolo L; Palermo A; Zanchetti A
J Hypertens; 1985 Feb; 3(1):55-61. PubMed ID: 2987342
[TBL] [Abstract][Full Text] [Related]
17. Circulatory effects of renin-angiotensin system antagonists during halothane anaesthesia in hypertensive rats.
Kaukinen S; Kataja J; Ylitalo P
Acta Anaesthesiol Scand; 1983 Feb; 27(1):81-6. PubMed ID: 6340406
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the chronotropic property of captopril in hypertensive patients.
Imai Y; Abe K; Sato M; Haruyama T; Hiwatari M; Goto T; Sato K; Kasai Y; Tajima J; Yoshinaga K
Am Heart J; 1982 Dec; 104(6):1339-45. PubMed ID: 6128916
[TBL] [Abstract][Full Text] [Related]
19. Effects of captopril (SQ 14, 225) on the renin-angiotensin-aldosterone system in normal rats.
Kokubu T; Ueda E; Ono M; Kawabe T; Hayashi Y; Kan T
Eur J Pharmacol; 1980 Apr; 62(4):269-75. PubMed ID: 6245897
[TBL] [Abstract][Full Text] [Related]
20. Evidence for prejunctional inhibition of norepinephrine release by captopril in spontaneously hypertensive rats.
Antonaccio MJ; Kerwin L
Eur J Pharmacol; 1980 Nov; 68(2):209-12. PubMed ID: 7009166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
